Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug Interactions

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00600
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?

Journal of Cancer
Oncology
2016English

Species Difference in the Inhibition of Drug Metabolism in Liver Microsomes by SKF 525a

The Japanese Journal of Pharmacology
1966English

Carbonyl-Carbonyl Interactions in First-Row Transition Metal Complexes

Acta Crystallographica Section A Foundations of Crystallography
2005English

The Impact of Formulation, Delivery, and Dosing Regimen on the Risk of Drug–Drug Interactions

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Substrate Induced Difference Spectrum of Microsomal P-450 in Human Liver

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1971English

The Stereospecificity of the Reduction of Nitrate by Reduced Nicotinamide-Adenine Dinucleotides Catalysed byCandida Utilispreparations

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1982English

Hydrogen-Bonding and Carbonyl–carbonyl Interactions in Violuric Acid Methanol Solvate

Acta Crystallographica Section C Crystal Structure Communications
2005English

Drug Interactions Using Human Hepatic Samples.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Mechanism of Drug–Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer

Biochemistry
Biochemistry
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy